SGLT2 inhibitors and risk of atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis of observational studies
SGLT2i therapy is associated with a significantly lower risk of AF recurrence after CA, independent of diabetic status. Further randomized controlled trials are warranted to validate these findings and explore the mechanisms underlying this association.
Authors
- Luca Canovi (ORCID: https://orcid.org/0009-0005-5006-156X)
- Alessandro Fucili (ORCID: https://orcid.org/0000-0002-1843-2923)
- Michele Malagù (ORCID: https://orcid.org/0000-0002-1972-9665)
- Matteo Bertini (ORCID: https://orcid.org/0000-0002-5285-7140)
- Matteo Serenelli
- Cristina Balla (ORCID: https://orcid.org/0000-0003-2110-8961)
- Marco Zuin (ORCID: https://orcid.org/0000-0002-4559-1292)
- Francesco Vitali (ORCID: https://orcid.org/0000-0002-0667-7616)
Institutions
- University of Padua (IT)
- University of Ferrara (IT)
- Hospital Madre Teresa (BR)
- ERN GUARD-Heart (NL)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.hroo.2025.10.017
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00